These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21565604)

  • 41. [The changes in the interaction of the brain hemispheres in the course of drug therapy of psychosis].
    Ivanov OV
    Zh Evol Biokhim Fiziol; 2003; 39(1):104-9. PubMed ID: 12739274
    [No Abstract]   [Full Text] [Related]  

  • 42. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement in refractory psychosis with dronabinol: four case reports.
    Schwarcz G; Karajgi B
    J Clin Psychiatry; 2010 Nov; 71(11):1552-3. PubMed ID: 21114952
    [No Abstract]   [Full Text] [Related]  

  • 44. Improvement of tinnitus with trifluoperazine in a patient with psychosis and ear disease.
    Jain S; Srivastava AS; Madhu ; Maggu G; Pandey M
    Asian J Psychiatr; 2017 Dec; 30():177-178. PubMed ID: 29080514
    [No Abstract]   [Full Text] [Related]  

  • 45. Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes.
    Mohandas P; Bewley A; Taylor R
    J Dermatolog Treat; 2018 Mar; 29(2):208-213. PubMed ID: 28665169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of psychosis with prochlorperazine in the ICU setting.
    Servis M; Miller B
    Psychosomatics; 1997; 38(6):589-90. PubMed ID: 9518347
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypnosis in the treatment of Morgellons disease: a case study.
    Gartner AM; Dolan SL; Stanford MS; Elkins GR
    Int J Clin Exp Hypn; 2011 Apr; 59(2):242-9. PubMed ID: 21390982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delusional parasitosis facilitated by web-based dissemination.
    Vila-Rodriguez F; Macewan BG
    Am J Psychiatry; 2008 Dec; 165(12):1612. PubMed ID: 19047336
    [No Abstract]   [Full Text] [Related]  

  • 49. Morgellons disease: more questions than answers.
    Stricker RB; Middelveen MJ
    Psychosomatics; 2012; 53(5):504-5; author reply 505-6. PubMed ID: 22959062
    [No Abstract]   [Full Text] [Related]  

  • 50. The first investigative science-based evidence of Morgellons psychogenesis.
    Roncati L; Gatti AM; Pusiol T; Piscioli F; Barbolini G; Maiorana A
    Ultrastruct Pathol; 2016; 40(5):249-53. PubMed ID: 27269255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical neuroleptics, dose-response relationships, and treatment-resistant psychosis.
    Cohen BM; Benes FM; Baldessarini RJ
    Arch Gen Psychiatry; 1989 Apr; 46(4):381-3. PubMed ID: 2564764
    [No Abstract]   [Full Text] [Related]  

  • 52. New treatments for depression with psychosis. Two experimental treatments for depression have shown promise in preliminary studies; one a relatively new drug, the other a familiar hormone.
    Harv Ment Health Lett; 2003 Aug; 20(2):3-5. PubMed ID: 12936867
    [No Abstract]   [Full Text] [Related]  

  • 53. Morgellons disease leading to corneal perforation and enucleation.
    Ma J; Roelofs KA; Badilla J
    Can J Ophthalmol; 2019 Dec; 54(6):e285-e288. PubMed ID: 31836115
    [No Abstract]   [Full Text] [Related]  

  • 54. Choosing the appropriate pharmacotherapy for Morgellons disease: an expert perspective.
    Balogh EA; Beuerlein KG; Feldman SR
    Expert Opin Pharmacother; 2022 Apr; 23(5):527-530. PubMed ID: 35076344
    [No Abstract]   [Full Text] [Related]  

  • 55. Delusional parasitosis and the matchbox sign revisited: the international perspective.
    Freudenmann RW; Kölle M; Schönfeldt-Lecuona C; Dieckmann S; Harth W; Lepping P
    Acta Derm Venereol; 2010 Sep; 90(5):517-9. PubMed ID: 20814630
    [No Abstract]   [Full Text] [Related]  

  • 56. Delusional infestation versus Morgellons disease.
    Hylwa SA; Ronkainen SD
    Clin Dermatol; 2018; 36(6):714-718. PubMed ID: 30446193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychosis as a Dialectic of Aha- and Anti-Aha-Experiences.
    Sips R
    Schizophr Bull; 2019 Sep; 45(5):952-955. PubMed ID: 29846714
    [No Abstract]   [Full Text] [Related]  

  • 58. Morgellons disease: insights into treatment.
    Aung-Din D; Sahni DR; Jorizzo JL; Feldman SR
    Dermatol Online J; 2018 Nov; 24(11):. PubMed ID: 30695970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Morgellons, a 'socially transmitted' disease].
    van der Bent SAS; Kemperman PM; Vulink NC; Hoekzema R
    Ned Tijdschr Geneeskd; 2019 Nov; 163():. PubMed ID: 31750635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case report highlighting the growing trend of Internet-based self-diagnosis of "Morgellon's disease".
    Mortillaro G; Rodgman C; Kinzie E; Ryals S
    J La State Med Soc; 2013; 165(6):334-6. PubMed ID: 25073260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.